Dilated Cardiomyopathy

  • Michael Y. HeneinEmail author
  • Mary Sheppard
  • John R. Pepper


Dilated cardiomyopathy is characterized by left ventricular dilatation, increased end diastolic volume, and reduced systolic function (typically ejection fraction less than 40%) [1, 2].


Mitral Regurgitation Dilate Cardiomyopathy Cardiac Resynchronization Therapy Tricuspid Regurgitation Atrial Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

Video 9.1

Parasternal long axis view from a patient with dilated cardiomyopathy showing poor overall systolic function

video 1.avi (3,667 KB)

76621_2_En_9_MOESM2_ESM.mpg (2.4 mb)
Video 9.2 Parasternal long axis view from a patient with advanced dilated cardiomyopathy with poor systolic function and spontaneous echo contrast, because of cavity dyssynchrony video 2.avi (2,440 KB)
Video 9.3

Apical views from a patient with DCM and functional mitral regurgitation

video 3.avi (1,602 KB)

Video 9.4

Apical 4 chamber view from a patient with dilated cardiomyopathy showing poor LV systolic function and spontaneous echo contrast

Video 4.AVI (5,007 KB)

76621_2_En_9_MOESM5_ESM.mpg (8.3 mb)
Video 9.5 Apical 4 chamber views from the same patient after ­optimum left atrial pressure offloading therapy with vasodilators. Note the reduction in left atrial size and disappearance of mitral regurgitation Video 5.avi (8,468 KB)
Video 9.6

3D echo technique showing segmental left ventricular dyssynchrony

Video 6.avi (3,186 KB)


  1. 1.
    Goodwin JF. Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet. 1970;1(7650):732–9.PubMedGoogle Scholar
  2. 2.
    Corya B, Feigenbaum H, Rasmussen S, Black MJ. Echocardiographic features of congestive cardiomyopathy compared with normal subjects and patients with coronary artery disease. Circulation. 1974;49(6):1153–9.PubMedGoogle Scholar
  3. 3.
    Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87(6):1854–65.PubMedGoogle Scholar
  4. 4.
    Hadjimiltiades S, Panidis IP, Segal BL, Iskandrian AS. Recovery of left ventricular function in peripartum cardiomyopathy. Am Heart J. 1986;112(5):1097–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J. 1991;121(6 Pt 1):1776–8.PubMedGoogle Scholar
  6. 6.
    Cambridge G, MacArthur CG, Waterson AP, Goodwin JF, Oakley CM. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1979;41(6):692–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Obeyesekere I, Hermon Y. Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever – a follow-up study. Am Heart J. 1973;85(2):186–94.PubMedCrossRefGoogle Scholar
  8. 8.
    Corallo S, Mutinelli MR, Moroni M, Lazzarin A, Celano V, Repossini A, et al. Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. Eur Heart J. 1988;9(8):887–92.PubMedGoogle Scholar
  9. 9.
    Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, et al. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol. 1993;71(11):955–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Abelmann WH, Lorell BH. The challenge of cardiomyopathy. J Am Coll Cardiol. 1989;13(6):1219–39.PubMedCrossRefGoogle Scholar
  11. 11.
    DeMaria AN, Bommer W, Lee G, Mason DT. Value and limitations of two dimensional echocardiography in assessment of cardiomyopathy. Am J Cardiol. 1980;46(7):1224–31.PubMedCrossRefGoogle Scholar
  12. 12.
    Medina R, Panidis IP, Morganroth J, Kotler MN, Mintz GS. The value of echocardiographic regional wall motion abnormalities in detecting coronary artery disease in patients with or without a dilated left ventricle. Am Heart J. 1985;109(4):799–803.PubMedCrossRefGoogle Scholar
  13. 13.
    Wallis DE, O’Connell JB, Henkin RE, Costanzo-Nordin MR, Scanlon PJ. Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. J Am Coll Cardiol. 1984;4(4):674–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Yazawa Y, Hayashi S, Hosokawa O, Watanabe K, Takano S, Ohno M, et al. Regional wall motion of the left ventricle in congestive cardiomyopathy: in comparison with progressive muscular dystrophy of Duchenne type (author’s transl). J Cardiogr. 1981;11(4):1233–9.PubMedGoogle Scholar
  15. 15.
    Laskey WK, Sutton MS, Zeevi G, Hirshfeld Jr JW, Reichek N. Left ventricular mechanics in dilated cardiomyopathy. Am J Cardiol. 1984;54(6):620–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Takenaka K, Dabestani A, Gardin JM, Russell D, Clark S, Allfie A, et al. Pulsed Doppler echocardiographic study of left ventricular filling in dilated cardiomyopathy. Am J Cardiol. 1986;58(1):143–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Appleton CP, Hatle LK, Popp RL. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol. 1988;11(4):757–68.PubMedCrossRefGoogle Scholar
  18. 18.
    Henein MY, Gibson DG. Abnormal subendocardial function in restrictive left ventricular disease. Br Heart J. 1994;72(3):237–42.PubMedCrossRefGoogle Scholar
  19. 19.
    Henein MY, O’Sullivan CA, Coats AJ, Gibson DG. Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease. J Am Coll Cardiol. 1998;32(5):1187–93.PubMedCrossRefGoogle Scholar
  20. 20.
    Henein MY, Amadi A, O’Sullivan C, Coats A, Gibson DG. ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease. Heart. 1996;76(4):326–31.PubMedCrossRefGoogle Scholar
  21. 21.
    Dickerman SA, Rubler S. Mitral and tricuspid valve regurgitation in dilated cardiomyopathy. Am J Cardiol. 1989;63(9):629–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER, et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J. 2008;29(6):757–65. Epub Feb 27, 2008.PubMedCrossRefGoogle Scholar
  23. 23.
    Donal E, De Place C, Kervio G, Bauer F, Gervais R, Leclercq C, et al. Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony. Eur J Echocardiogr. 2009;10(1):133–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Nishimura RA, Abel MD, Hatle LK, Tajik AJ. Relation of pulmonary vein to mitral flow velocities by transesophageal Doppler echocardiography. Effect of different loading conditions. Circulation. 1990;81(5):1488–97.PubMedCrossRefGoogle Scholar
  25. 25.
    Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and ­hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. J Am Coll Cardiol. 1993;22(3):808–15.PubMedCrossRefGoogle Scholar
  26. 26.
    Rossvoll O, Hatle LK. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol. 1993;21(7):1687–96.PubMedCrossRefGoogle Scholar
  27. 27.
    Ritter S, Tani LY, Shaddy RE, Day RW, Orsmond GS, Pagotto LT, et al. Can Doppler systemic venous flow indices predict central venous pressure in children? Echocardiography. 2000;17(2):127–32.PubMedCrossRefGoogle Scholar
  28. 28.
    Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70(4):657–62.PubMedCrossRefGoogle Scholar
  29. 29.
    Gottdiener JS, Gay JA, VanVoorhees L, DiBianco R, Fletcher RD. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am J Cardiol. 1983;52(10):1281–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Asinger RW, Mikell FL, Sharma B, Hodges M. Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses. Am J Cardiol. 1981;47(1):145–56.PubMedCrossRefGoogle Scholar
  31. 31.
    Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart. 2002;88(1):47–51.PubMedCrossRefGoogle Scholar
  32. 32.
    Yamazaki T, Froelicher VF, Myers J, Chun S, Wang P. Spatial QRS-T angle predicts cardiac death in a clinical population. Heart Rhythm. 2005;2(1):73–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet. 1992;340(8831):1308–12.PubMedCrossRefGoogle Scholar
  34. 34.
    The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429–35.Google Scholar
  35. 35.
    Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283(10):1295–302.PubMedCrossRefGoogle Scholar
  36. 36.
    Yu CM, Lin H, Fung WH, Zhang Q, Kong SL, Sanderson JE. Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure. Am Heart J. 2003;145(5):E18.PubMedCrossRefGoogle Scholar
  37. 37.
    Duncan AM, Lim E, Clague J, Gibson DG, Henein MY. Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. Eur Heart J. 2006;27(20):2426–32. Epub Aug 1, 2006.PubMedCrossRefGoogle Scholar
  38. 38.
    Kapetanakis S, Bhan A, Murgatroyd F, Kearney MT, Gall N, Zhang Q, et al. Real-time 3D echo in patient selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2011;4(1):16–26.PubMedCrossRefGoogle Scholar
  39. 39.
    Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol. 2008;52(6):438–45.PubMedCrossRefGoogle Scholar
  40. 40.
    van Geldorp IE, Delhaas T, Hermans B, Vernooy K, Broers B, Klimusina J, et al. Comparison of a non-invasive arterial pulse contour technique and echo Doppler aorta velocity-time integral on stroke volume changes in optimization of cardiac resynchronization therapy. Europace. 2011;13(1):87–95. Epub Sep 29, 2010.PubMedCrossRefGoogle Scholar
  41. 41.
    Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–80.PubMedCrossRefGoogle Scholar
  42. 42.
    Salukhe TV, Francis DP, Clague JR, Sutton R, Poole-Wilson P, Henein MY. Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern. Int J Cardiol. 2005;100(1):5–12.PubMedCrossRefGoogle Scholar
  43. 43.
    Dalby MC, Banner NR, Tansley P, Grieve LA, Partridge J, Yacoub MH. Left ventricular function during support with an asynchronous pulsatile left ventricular assist device. J Heart Lung Transplant. 2003;22(3):292–300.PubMedCrossRefGoogle Scholar
  44. 44.
    Henein M, Birks EJ, Tansley PD, Bowles CT, Yacoub MH. Images in cardiovascular medicine. Temporal and spatial changes in left ventricular pattern of flow during continuous assist device “HeartMate II”. Circulation. 2002;105(19):2324–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Ghio S, Recusani F, Klersy C, Sebastiani R, Laudisa ML, Campana C, et al. Prognostic usefulness of the tricuspid annular plane ­systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol. 2000;85(7):837–42.PubMedCrossRefGoogle Scholar
  46. 46.
    Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40(1):111–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845–53.PubMedCrossRefGoogle Scholar
  48. 48.
    Patel AR, Lima C, Parro A, Arsenault M, Vannan MA, Pandian NG. Echocardiographic analysis of regional and global left ventricular shape in Chagas’ cardiomyopathy. Am J Cardiol. 1998;82(2):197–202.PubMedCrossRefGoogle Scholar
  49. 49.
    Kisslo J. Two-dimensional echocardiography in arrhythmogenic right ventricular dysplasia. Eur Heart J. 1989;10(Suppl D):22–6.PubMedGoogle Scholar
  50. 50.
    Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2009;360(11):1075–84.PubMedCrossRefGoogle Scholar
  51. 51.
    Nousiainen T, Jantunen E, Vanninen E, Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002;86(11):1697–700.PubMedCrossRefGoogle Scholar
  52. 52.
    de Kermadec JM, Becane HM, Chenard A, Tertrain F, Weiss Y. Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. Am Heart J. 1994;127(3):618–23.PubMedCrossRefGoogle Scholar
  53. 53.
    Lindqvist P, Mörner S, Olofsson BO, Backman C, Lundblad D, Forsberg H, et al. Ventricular dysfunction in type 1 myotonic dystrophy: electrical, mechanical, or both? Int J Cardiol. 2010;143(3):378–84. Epub Apr 22, 2009.PubMedCrossRefGoogle Scholar
  54. 54.
    Mörner S, Lindqvist P, Mellberg C, Olofsson BO, Backman C, Henein M, et al. Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1. Intern Med. 2010;268(1):59–65. Epub Jan 11, 2010.Google Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  • Michael Y. Henein
    • 1
    Email author
  • Mary Sheppard
    • 2
  • John R. Pepper
    • 2
  1. 1.Department of Public Health and Clinical Medical and Heart CenterUmea UniversityUmeaSweden
  2. 2.Royal Brompton HospitalLondonUK

Personalised recommendations